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Abstract
Background: There has been a recent growth in the use of whole body Computerised Tomography (CT) scans in
the private sector as a screening test for asymptomatic disease. This is despite scant evidence to show any positive
effect on morbidity or mortality. There has been concern raised over the possible harms of the test in terms of
radiation exposure as well as the risk and anxiety of further investigation and treatment for the large numbers of
benign lesions identified.
Case Presentation: A healthy 64 year old lady received a privately funded whole body CT scan for her birthday
which revealed an incidental mass in the right iliac fossa. This was investigated with further imaging and
colonoscopy and as confident diagnosis could not be made, eventually excised. Histology demonstrated this to be
a benign ancient schwannoma and we believe this to be the first reported case of an abdominal wall
schwannoma in the English literature
Conclusions: Ancient schwannomas are rare tumours of the peripheral nerve sheaths more usually found in the
head, neck and flexor surfaces of extremities. They are a subtype of classical schwannomas with a predominance of
degenerative changes. Our case highlights the pitfalls of such screening tests in demonstrating benign disease and
subjecting patients to what turns out to be unnecessary invasive investigation and treatment. It provides evidence
as to the consequences of the large number of false positive results that are created by blind CT scanning of
asymptomatic patients i.e. its tendency to detect pseudodiesease rather than affect survival rates. Should the
number of scans increase there may be an unnecessary burden on NHS resources due to the large numbers of
benign lesions picked up, that are then referred for further investigation.
Background
In recent years private entrepreneurs have recognised,
some might say exploited, a market for radiological
screening tests [1,2]. One of these tests, Computerised
Tomography (CT), in particular whole body CT, is ten-
dered as a possible tool to identify asymptomatic thor-
acic and abdominal disease. However, before any
procedure is adopted to screen for disease, its cost, ben-
efit and risk should all be taken into account and before
this happens the value of the test must remain unproven
and unknown[3] To date, this evaluation has not been
carried out with whole body CT screening in asympto-
matic individuals [4]. This may be due to the huge cost
and long follow up period required for such a trial as
well as the fact that grants are unlikely to be given to
research what is increasingly seen as an entrepreneurial
scheme [2]. Hence, a number of clinical, ethical and
health-economical issues have been raised by medical
professionals in response to the growth of such an
unproven test in the private sector. Although these cen-
tre on the lack of evidence that blind CT scanning of
asymptomatic individuals produces any benefit in terms
of identifying or precluding disease, they also emphasise
the potential harm from radiation as well as from
further, often invasive, investigations which are offered
in the large number of false positive cases frequently
seen. Furthermore, some have voiced concern at the
growing public expenditure spent on investigating the
large number incidental lesions uncovered on private
CT scans. In this paper, we present our treatment for a
lesion identified on a private whole body CT scan, given
to our patient as a birthday present, as well as recount
what we believe to be the first reported case in the
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noma. We discuss the clinical, histological and radiolo-
gical features of ancient schwannomas, as well as
discuss in further depth, the controversy surrounding
whole body CT screening in asymptomatic individuals.
Case Report
A healthy 64 year old lady received a LifeScan (privately
funded whole body CT scan) for her birthday which
revealed an incidental mass in the right iliac fossa (RIF).
This was investigated further with a colonoscopy which
revealed small benign polyps only. Initially a putative
diagnosis of GastroIntestinal Stromal Tumour (GIST)
was considered and the patient referred to our NHS
Colorectal outpatient clinic.
Clinically, the lady was well with no weight loss, anae-
mia, change in bowel habit or loss of appetite. She com-
plained of RIF discomfort but admitted that this had
only manifested since her CT scan. She was extremely
anxious about her condition and the underlying diagno-
sis. On examination, a non-tender 8 cm mass was palp-
able in the RIF and a routine blood screen was entirely
normal. The case was discussed at the Lower Gastroin-
testinal Multidisciplinary Team (MDT) meeting and it
was agreed that a repeat CT scan with contrast should
be performed. The scan demonstrated a 6 × 5 cm
heterogeneous mass in the RIF adjacent to the perito-
neal wall (Figure 1). No other abnormality was evident
but a normal appendix could not be identified. These
findings were discussed again at the MDT meeting and
a differential diagnosis of mucinous tumour or chronic
mucocele of the appendix was suggested.
The possible diagnoses were discussed with the
patient and after consideration of the risks and benefits,
she agreed to surgery by a laparoscopic approach. At
laparoscopy a 6 × 4 × 3.5 cm extraperitoneal ovoid
nodule was found on the abdominal wall in the RIF. In
light of the unusual appearances, the procedure was
converted to laparotomy but no intra-peritoneal pathol-
ogy was noted. The lesion was excised and sent for his-
tological examination. Macroscopically, it had a solid
cut surface with tan, brown and cream areas and con-
tained a 1.2 cm cyst. Microscopically, it was composed
of hypocellular and hypercellular areas. The hypocellular
areas were oedematous and myxoid, containing chronic
inflammatory cells and spindle cells which were hapha-
zardly arranged, aggregating in areas to form small focal
palisades. The spindle cells showed hyperchromatic and
irregular nuclei although no mitotic figures were seen
(Figures 2 and 3). There were several foci of stromal
hyalinisation and sclerosis, with numerous ectatic blood
vessels. Immunohistochemistry showed that the spindle
Figure 1 Saggital section of CT Abdomen with Contrast. Well circumscribed RIF mass next to anterior abdominal wall.
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diagnosis of benign ancient schwannoma was made.
Postoperatively, the patient recovered well and was dis-
charged 2 days after surgery. She is now asymptomatic.
Conclusions
Ancient schwannomas are rare tumours originating
from Schwann cells in the peripheral nerve sheath [5].
Up to 20% of cases are associated with Neurofibromato-
sis Type 1 [6]. They usually arise in females [7] between
the ages of 20-50 years, [6] with a predilection for the
head, neck and flexor surfaces of extremities [8,9]. How-
ever, there have been sporadic cases of these tumours
arising in the retroperitoneum, pelvis, perineum, adre-
nals, kidneys and even masquerading as an inguinal her-
nia [9-14]. They may be asymptomatic and only found
incidentally on examination or imaging. However, occa-
sionally they produce pressure effects on surrounding
large nerves [15].
Ancient schwannomas are a subtype of classic
schwannomas with a predominance of degenerative
changes including cyst formation, calcification, haemosi-
derin deposition, interstitial fibrosis, and vascular hyaline
degeneration [16]. They show spindle cells with focal
nuclear palisading patterns [6] arranged in distinctive
dense (Antoni A) and loose (Antoni B) areas [6,16].
Usually, connective tissue fragments (Verocay bodies)
and intranuclear vacuoles (lochkern) are present [17-19].
These features may sometimes be seen on CT, which
may demonstrate a well circumscribed, heterogeneous
mass of low density which fits with the microscopic pat-
tern of cellular and hypocellular areas. The term
“ancient” was used as a description for the degenerative
changes apparent on microscopy [20,21] which was
thought to be due to the increasing tumour size causing
vascular insufficiency [22].
There have been less than ten reports in the literature
of malignant lesions arising from schwannomas [23-25]
although some argue that these malignant tumours may
arise de novo [7] rather than having undergone second-
ary anaplastic change [19,26] and that recurrence after
resection may actually be due to incomplete excision
[27].
Schwannomas react strongly with S100 protein and
immunohistochemistry can be used to aid diagnosis and
to differentiate them from malignant peripheral nerve
sheath tumours [24,28,29]. This is especially helpful as
the occasional appearance of hyperchromatic cells and
cytological atypia may lead to diagnostic difficulty
[19,22] especially when fine needle aspiration cytology
(FNAc) is used to make a diagnosis
[5,7,18,21,22,28,30,31] as this technique rarely produces
an adequate enough sample [29]. False positive diagnosis
of malignancy may lead to over treatment with radical
resections being carried out unnecessarily. Together
with the clinical history, the characteristic radiological
findings may help distinguish schwannomas and prevent
unnecessary resection for such a benign condition
[32-34]. However, as in our case, this is rarely possible
and surgical resection is still common [6,27,35,36].
Our case highlights one of the main pitfalls of whole
body CT scan used as a screening method for disease.
This lady suffered considerable mental anguish, endured
extremely invasive procedures and the significant risks
that accompany them, for a condition that may never
have caused any symptoms. Studies have shown that up
to 86% patients who undergo these scans show at least
one abnormal finding and up to 37% of individuals
receive recommendations for further investigation [37].
Figure 2 Microscopic appearance of the lesion.P r o n o u n c e d
degenerative changes including myxoid stroma, haemorrhage,
conspicuous blood vessels with hyaline thickening of walls and
luminal thrombosis (H&E ×20)
Figure 3 Microscopic appearance of the lesion Focal marked
nuclear pleomorphism, with isolated cells having bizarre
hyperchromatic nuclei (H&E ×60)
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cance is doubtful. Given the large number of findings
identified by such a crude test, there have been calls for
guidelines to be drawn up to as to help clinicians decide
which abnormalities warrant further investigation
[38,39]. Although such guidelines may be helpful, this
may be harder for lesions detected on abdominal or pel-
vic CT given that the often non contrast CT method
used for screening, rarely provides enough detailed
information on which to guide management. Addition-
ally, different guidelines would have to be drawn up for
different organs. Yet this would have been of little bene-
fit in our case as the lesion was adherent to the anterior
abdominal wall. In spite of this, the few supporters of
screening CT do point out that as with mammograms,
false positive results may decrease with increased use
and experience of the test [40].
As well as the high false positive rate, the other main
criticism levelled is that there is scant evidence that
whole body CT reduces morbidity or mortality [2] even
if it were to correctly identify true positives or negatives.
For example, lead time bias may mean earlier diagnosis
of disease but not improved survival. Length bias may
mean overrepresented diagnoses of slower progressing
d i s e a s e( m o r el i k e l yt ob ep i c k e du pb yas t a t i cs c r e e n -
ing test such as a CT scan) but again not actually
improved survival times. Overdiagnosis bias (demon-
strated effectively in our case) occurs when pseudodie-
sease- i.e. cases that probably wouldn’t have caused
disease were they not picked up, is not adjusted for [41].
True negative results would of course reassure indivi-
duals, however this may lead them carrying on with
unhealthy lifestyle habits in the knowledge that they
have been given the “all clear”. Of course, false negatives
are probably the worst outcomes for both the patient
and reporting radiologist [2].
Given the lack of evidence of any tangible benefit of
CT screening tests, some have speculated they may
actually do more harm than good. There is an ongoing
debate as to whether the risks of radiation from whole
body CT may be harmful to asymptomatic individuals
and differences stem from the calculation of radiation
dose depending on type of scanner and protocol used or
whether interval CT scans are offered [42,43]. Although
it is hard to prove these associations, given that we are
cautious with regards to radiation exposure in our usual
practice it seems prudent to apply the same hesitancy
when it comes to unproven screening tests.
But what for the argument that CT screening tests
offer individuals control over their own healthcare for
those that can afford it? Although patients who present
for these tests may value the consumer empowerment
over their healthcare management and desire “compre-
hensive wellness” (i.e. assurance that they are free of
disease even in the absence of symptoms), [44] one has
to remember that CT screening may have a large false
positive rate and as in our report, the costs of the addi-
tional investigations will mostly be borne by the NHS,
despite the initial screening test being performed in the
private sector. There is concern that should CT screen-
ing become more widespread, the financial burden of
distinguishing the incidentalomas from true disease be
may end up being shared by the taxpayer and thereby
increase national health expenditure [1,44] hence widen-
ing the disparity of healthcare options for the less well-
off [44]. Of course this is an argument that may be
made of other unproven treatments performed only in
the private sector. However the targeted marketing of
CT screening to the asymptomatic, economically com-
fortable and educated health conscious consumer [45]
as well as the prima fasciae logic embedded such a test
should the benefits and risks not be adequately
explained, brings the potential for a huge number of
“worried well” presenting to publicly funded surgical
outpatients clinics.
In this study we have presented the first reported case
in the English literature of an abdominal wall ancient
schwannoma and discussed the key clinical, radiological
and pathological features of the condition. As this was
picked up asymptomatically on a private health whole
body CT screen given to the patient as a birthday pre-
sent, we have extolled the pitfalls of such tests as well as
offered an insight into the clinical, ethical and health
economic issues that they raise. Wider marketing and
availability of these services may lead to increased non
evidence based patient-led screening in the private sec-
tor. Unfortunately, this may add an unnecessary burden
to public health resources.
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